Supply Chain Intelligence

Seres Therapeutics, Inc. Supply Chain

MCRB supply chain intelligence for Seres Therapeutics, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

MCRB ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

4Suppliers
4Customers
3Debt Items
20Related Chains

Seres Therapeutics, Inc. Suppliers

TickerNameConfidenceEvidence
101-CPD-LLC 101-CPD-LLC 90% the Company entered into the First Amendment to Lease with 101 CPD LLC (f/k/a HCP/King 101 CPD LLC), a Delaware limited liability company (the “Landlord”), which amends the Lease Agreement
NESTL-ENTERPRISES-S-A NESTL-ENTERPRISES-S-A 90% The Company entered into a Transition Services Agreement ("TSA") with Nestlé Enterprises S.A., ("NESA"), an affiliate of SPN, in connection with the Transaction, through which the Company provided ce…
MYGN Myriad Genetics, Inc. 72% , there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation or other proceedings. In addition, during the course of this kind of liti…
MYGN Myriad Genetics, Inc. 72% Reciprocal relationship from MYGN graph: Reciprocal relationship from MCRB graph: Reciprocal relationship from MYGN graph: Reciprocal relationship from MCRB graph: Reciprocal relationship from MYGN g…

Seres Therapeutics, Inc. Customers

TickerNameConfidenceEvidence
SOCI-T-DES-PRODUITS-NESTL-S-A SOCI-T-DES-PRODUITS-NESTL-S-A 92% Pursuant to the Purchase Agreement, SPN agreed to pay the Company certain one-time contingent milestone payments during the Milestone Period
MYGN Myriad Genetics, Inc. 72% , there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation or other proceedings. In addition, during the course of this kind of liti…
MYGN Myriad Genetics, Inc. 72% Reciprocal relationship from MYGN graph: Reciprocal relationship from MCRB graph: , there is a risk that some of our confidential information could be compromised by disclosure during this type of li…
TOVX Theriva Biologics, Inc. 72% Reciprocal relationship from TOVX graph: prescribe legally available drugs for off-label uses, drugs may be marketed only for the approved indications and in accordance with the provisions of the app…

Seres Therapeutics, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
MCRB-DEBT-10899 Xbrl Convertible 90% xbrl convertible detail from xbrl 2015-12-31.
MCRB-DEBT Debt stack $80.5M 90% Market cache reports total debt of $80.5M.
MCRB-DEBT-10898 Warrants outstanding: 2785000 90% xbrl warrant detail from xbrl 2025-12-31.

Seres Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Seres Therapeutics, Inc..

Seres Therapeutics, Inc. Ownership

HolderNameConfidenceEvidence
MCRB-OWNER-FLAGSHIP-PIONEERING-LLC Flagship Pioneering, LLC 90% 13F overlay lists Flagship Pioneering, LLC as top holder; 35 tracked holders.

Seres Therapeutics, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
HOWL Werewolf Therapeutics, Inc. 100.00 2
BTAI BioXcel Therapeutics, Inc. 100.00 2
BIAF bioAffinity Technologies, Inc. 100.00 2
IMNM Immunome, Inc. 100.00 2
BNBX BNB Plus Corp. 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
ATYR aTyr Pharma, Inc. 100.00 2
DSGN Design Therapeutics, Inc. 100.00 2
PSNL Personalis, Inc. 100.00 2
ESTA Establishment Labs Holdings Inc. 100.00 2
BNTC Benitec Biopharma Inc. 100.00 2
CALC CalciMedica, Inc. 100.00 2
ALLO Allogene Therapeutics, Inc. 100.00 2
SDGR Schrödinger, Inc. 100.00 2
TECX Tectonic Therapeutic, Inc. 100.00 2
ELVN Enliven Therapeutics, Inc. 100.00 2
CLGN CollPlant Biotechnologies Ltd. 100.00 2
CABA Cabaletta Bio, Inc. 100.00 2
ADCT ADC Therapeutics SA 100.00 2
TPST Tempest Therapeutics, Inc. 100.00 2
View MCRB supply chain intel →

Explore the full interactive supply chain map for Seres Therapeutics, Inc..

Open MCRB supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map